1. Home
  2. LCFY vs SCNI Comparison

LCFY vs SCNI Comparison

Compare LCFY & SCNI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • LCFY
  • SCNI
  • Stock Information
  • Founded
  • LCFY 2009
  • SCNI 2003
  • Country
  • LCFY Australia
  • SCNI Israel
  • Employees
  • LCFY N/A
  • SCNI N/A
  • Industry
  • LCFY
  • SCNI Biotechnology: Biological Products (No Diagnostic Substances)
  • Sector
  • LCFY
  • SCNI Health Care
  • Exchange
  • LCFY Nasdaq
  • SCNI Nasdaq
  • Market Cap
  • LCFY 3.7M
  • SCNI 3.2M
  • IPO Year
  • LCFY 2022
  • SCNI N/A
  • Fundamental
  • Price
  • LCFY $6.30
  • SCNI $2.23
  • Analyst Decision
  • LCFY
  • SCNI
  • Analyst Count
  • LCFY 0
  • SCNI 0
  • Target Price
  • LCFY N/A
  • SCNI N/A
  • AVG Volume (30 Days)
  • LCFY 4.9M
  • SCNI 1.1M
  • Earning Date
  • LCFY 07-07-2025
  • SCNI 08-14-2025
  • Dividend Yield
  • LCFY N/A
  • SCNI N/A
  • EPS Growth
  • LCFY N/A
  • SCNI N/A
  • EPS
  • LCFY N/A
  • SCNI N/A
  • Revenue
  • LCFY $2,668,385.00
  • SCNI $658,000.00
  • Revenue This Year
  • LCFY N/A
  • SCNI N/A
  • Revenue Next Year
  • LCFY N/A
  • SCNI N/A
  • P/E Ratio
  • LCFY N/A
  • SCNI N/A
  • Revenue Growth
  • LCFY N/A
  • SCNI N/A
  • 52 Week Low
  • LCFY $2.28
  • SCNI $1.90
  • 52 Week High
  • LCFY $13.98
  • SCNI $8.92
  • Technical
  • Relative Strength Index (RSI)
  • LCFY 63.49
  • SCNI 49.52
  • Support Level
  • LCFY $2.51
  • SCNI $2.15
  • Resistance Level
  • LCFY $13.98
  • SCNI $2.70
  • Average True Range (ATR)
  • LCFY 0.91
  • SCNI 0.22
  • MACD
  • LCFY 0.42
  • SCNI 0.01
  • Stochastic Oscillator
  • LCFY 33.04
  • SCNI 32.99

About LCFY Locafy Limited

Locafy Ltd is focused on commercializing its Software as a Service (SaaS) online publishing technology platform. Its platform enables the ability to publish almost any type of content to almost any device that uses a web browser to display web content. The firm has two operating segments: Publishing and SEO agency. Under the Publishing segment are products and services that the Company offers that are related to digital properties (i.e. mastheads) that it owns e.g. business data published on Hotfrog, advertising placed on AussieWeb, articles published on scoop.com.au. In contrast, under the SEO Agency segment are products and services that are applied to digital properties that are owned and operated by third parties. It derives a majority of its revenue in North America from SEO Agency.

About SCNI Scinai Immunotherapeutics Ltd.

Scinai Immunotherapeutics Ltd is a biopharmaceutical company with two complementary business units, one focused on in-house development of inflammation and immunology (I&I) biological therapeutic products beginning with a pipeline of nanosized VHH antibodies (NanoAbs) targeting diseases with large unmet medical needs, and the other a boutique CDMO providing services to help biotech companies efficiently bring their products to market by leveraging Scinai's drug development and GMP and non-GMP manufacturing capabilities for pre-clinical and clinical studies. The company generates maximum revenue from the provision of CDMO (Contract Development and Manufacturing Organization) services.

Share on Social Networks: